Comparison of pharmacokinetics and relative bioavailability of tablets and substance of new dipeptide neuroleptic dilept
- PMID: 25348562
- DOI: 10.1007/s10517-014-2655-1
Comparison of pharmacokinetics and relative bioavailability of tablets and substance of new dipeptide neuroleptic dilept
Abstract
We studied pharmacokinetics of dilept after single cross-administration of tablets and substance of dilept in a dose of 40 mg to rabbits. The following pharmacokinetic parameters were calculated: maximum plasma concentration of dilept, time to maximum observed concentration, area under the pharmacokinetic curve, elimination half-life, and relative bioavailability. Dilept concentration in blood plasma was estimated using ultra-fast liquid chromatography with mass spectrometry detection. Relative bioavailability of dilept tablets was 93.46±28.91% of that for the substance.
Similar articles
-
[Clinic pharmacokinetics of a new original antipsychotic drug Dilept].Eksp Klin Farmakol. 2013;76(6):34-7. Eksp Klin Farmakol. 2013. PMID: 24003489 Russian.
-
[Experimental pharmacokinetics of the new neurotensine-derived antipsychotic drug dilept].Eksp Klin Farmakol. 2009 May-Jun;72(3):16-21. Eksp Klin Farmakol. 2009. PMID: 19642587 Russian.
-
[Specific features in pharmacokinetics of the original neuroleptic dilept in animals and humans].Eksp Klin Farmakol. 2014;77(7):23-6. Eksp Klin Farmakol. 2014. PMID: 25322650 Clinical Trial. Russian.
-
[Neurotensine dipeptide analog dilept decreases the deficiency of prestimulus startle reflex inhibition: a prognostic sign of antipsychotic activity].Eksp Klin Farmakol. 2009 Sep-Oct;72(5):3-7. Eksp Klin Farmakol. 2009. PMID: 19928566 Russian.
-
[Dilept: a tripeptoid neurotensin analog combining neuroleptic activity with positive mnemotropic action].Eksp Klin Farmakol. 2005 Jan-Feb;68(1):3-6. Eksp Klin Farmakol. 2005. PMID: 15786954 Russian.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources